Hasil Pencarian - Xiaobo Cheng

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

    Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors oleh Chenli Qiu, Chenli Qiu, Jing Wang, Lingyan Zhu, Xiaobo Cheng, Xiaobo Cheng, Bili Xia, Yanling Jin, Ran Qin, LinXia Zhang, Huiliang Hu, Jia Yan, Chen Zhao, Xiaoyan Zhang, Xiaoyan Zhang, Jianqing Xu, Jianqing Xu

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)–octadecylamine conjugate for lung cancer treatment

    Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)–octadecylamine conjugate for lung cancer treatment oleh Xiang Luo, Ling Hu, Huangliang Zheng, Mingqi Liu, Xinrong Liu, Cong Li, Qiujun Qiu, Zitong Zhao, Xiaobo Cheng, Chaoyang Lai, Yuqing Su, Yihui Deng, Yanzhi Song

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

    A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 oleh Weihui Fu, Yan Liu, Lu Xia, Min Li, Zhigang Song, Huiliang Hu, Zongguo Yang, Lin Wang, Xiaobo Cheng, Mei Wang, Rongrong Jiang, Li Liu, Xiaoting Mao, Jun Chen, Yun Ling, Lin Zhang, Jin Yan, Fei Shan, Corklin Steinhart, Xiaoyan Zhang, Tongyu Zhu, Jianqing Xu, Hongzhou Lu

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19

    An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 oleh Weihui Fu, Yan Liu, Li Liu, Huiliang Hu, Xiaobo Cheng, Ping Liu, Zhigang Song, Lijun Zha, Shimeng Bai, Tingting Xu, Songhua Yuan, Fengru Lu, Zhiying Shang, Yihong Zhao, Jing Wang, Jun Zhao, Longfei Ding, Jun Chen, Lin Zhang, Tongyu Zhu, Xiaoyan Zhang, Hongzhou Lu, Jianqing Xu

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: